Tag: fda
Breaking News
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2024
– Revenue of $1,013.1 Million Exceeds Guidance –
– 5.2% Organic Constant Currency Revenue Growth ex. COVID-19, also Exceeding Guidance –
MARLBOROUGH, Mass.–(BUSINESS WIRE)–$HOLX #JPMC24–Hologic, Inc....
Nanowear Announces FDA 510(k) Clearance for AI-enabled Continuous Blood Pressure Monitoring and Hypertension Diagnostic Management: SimpleSense-BP
Utilizing patented nanosensors fueling transformative AI, SimpleSenseTM, is the first wearable platform that enables physicians to securely and accurately offer patients full routine cardiopulmonary...
U.S. Food and Drug Administration Approves ZELSUVMI™ as a First-in-Class Medication for the Treatment of Molluscum Contagiosum
ZELSUVMI™ is expected to be commercially available during the second half of 2024
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that the U.S....
Smart intravenous needle softens upon insertion into a blood vessel – Physics World
If a medical intravenous (IV) needle could soften upon insertion into the body, to match the softness of biological tissue, patients...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Methode Electronics, Inc. (MEI) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on...
Medical Ultrasound Equipment Global Strategic Business Report 2023: Market to Reach $10.2 Billion by 2030 – Technology Advances Spur Growth with AI at the...
DUBLIN–(BUSINESS WIRE)–The “Medical Ultrasound Equipment – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global Medical Ultrasound Equipment Market to Reach $10.2...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Inspire Medical Systems, Inc. (INSP) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on...
US Clinical Trial Data Management Service Market Focused Insights 2023-2028, with Profiles of Key Vendors IQVIA, SYNEOS, ICON & Labcorp – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Clinical Trial Data Management Service Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering.
There are over 8000 clinical...
USA Solid Tumor Therapeutics Market Outlook to 2028 – Field of Oncology is Moving Towards more Personalized Treatment – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “USA Solid Tumor Therapeutics Market Outlook to 2028” report has been added to ResearchAndMarkets.com’s offering.
The USA Solid Tumor Therapeutics Market refers to...
CRISPR Gene Editing Had a Breakthrough Year—and It’s Only Getting Started
CRISPR ended 2023 with a bang.In November, the gene editing tool scored its first clinical approval for treating sickle cell anemia and beta-thalassemia in...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Maison Solutions Inc. (MSS) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on...
After Weight Loss, Ozempic Is Set to Conquer a Universe of Brain Disorders
One inescapable word dominated biomedicine this year: Ozempic.Physicians were amazed at the drug’s efficacy in treating diabetes, for which it is FDA approved, and...
Latest Intelligence
